Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Anteris Technologies Global Corp.AVR · Entity 5089 | Director | June 07, 2026 | June 10, 2026 |
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · President and Director | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Anteris Technologies Global Corp.
Report date June 07, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,580 |
Reported balance
After 2026-06-07 transaction · row 1
1 source rowRow 1 · 2026-06-07 · Exercise / conversion · Acquired 17,580 · Balance 17,580 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,162 |
Reported balance
After 2026-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-07 · Exercise / conversion · Disposed 17,580 · Balance 35,162 F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.
F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 25.4682 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 24.7852 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 30.34 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 32.3815 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 17.5403 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 3.1566 · Balance 17.5403 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 18.6239 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 3.5757 · Balance 18.6239 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 1.9861 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 0.3056 · Balance 1.9861 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 2.0893 |
Reported balance
After 2026-09-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-03 · Grant · Acquired 0.3453 · Balance 2.0893 F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 13.6627 |
Reported balance
After 2026-09-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-09-03 · Grant · Acquired 5.2874 · Balance 13.6627 F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F9: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.2874 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 9 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13.6627 Underlying: Common Stock · 5.2874 shares Expires not disclosed F9 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.3453 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.0893 Underlying: Common Stock · 0.3453 shares Expires not disclosed F8 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.3056 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.9861 Underlying: Common Stock · 0.3056 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.5757 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18.6239 Underlying: Common Stock · 3.5757 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1566 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17.5403 Underlying: Common Stock · 3.1566 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.3524 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32.3815 Underlying: Common Stock · 4.3524 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.6322 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30.34 Underlying: Common Stock · 3.6322 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1262 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.7852 Underlying: Common Stock · 2.1262 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 03, 2026 Filed Sep 8, 2026 20:50 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1262 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-385321 · ownership.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25.4682 Underlying: Common Stock · 2.1262 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 07, 2026 Filed Jun 10, 2026 01:41 UTC | Anteris Technologies Global Corp. AVR · Entity 5089 | Exercise / conversionRestricted Stock Units · Derivative | 17,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-024699 · form4.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,162 Underlying: Common Stock · 17,580 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. F2 · derivative.exercise_date: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date. F2 · derivative.expiration_date: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| June 07, 2026 Filed Jun 10, 2026 01:41 UTC | Anteris Technologies Global Corp. AVR · Entity 5089 | Exercise / conversionCommon Stock | 17,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-26-024699 · form4.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.5367 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 9 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8.3753 Underlying: Common Stock · 4.5367 shares Expires not disclosed F9 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.2965 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.744 Underlying: Common Stock · 0.2965 shares Expires not disclosed F8 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.2622 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.6805 Underlying: Common Stock · 0.2622 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.0684 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15.0482 Underlying: Common Stock · 3.0684 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.7084 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14.3837 Underlying: Common Stock · 2.7084 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.7342 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28.0291 Underlying: Common Stock · 3.7342 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1166 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26.7078 Underlying: Common Stock · 3.1166 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8244 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22.659 Underlying: Common Stock · 1.8244 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 04, 2026 Filed Jun 5, 2026 21:31 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.8244 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-260002 · ownership.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23.342 Underlying: Common Stock · 1.8244 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.8386 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 9 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3.8386 Underlying: Common Stock · 3.8386 shares Expires not disclosed F9 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F9 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.2509 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.4475 Underlying: Common Stock · 0.2509 shares Expires not disclosed F8 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 0.2217 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1.4183 Underlying: Common Stock · 0.2217 shares Expires not disclosed F7 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.5959 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.9798 Underlying: Common Stock · 2.5959 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.2914 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11.6753 Underlying: Common Stock · 2.2914 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.1596 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24.2949 Underlying: Common Stock · 3.1596 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.6368 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23.5912 Underlying: Common Stock · 2.6368 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5436 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20.8346 Underlying: Common Stock · 1.5436 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 26, 2026 Filed Mar 30, 2026 21:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.5436 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-132163 · ownership.xml · derivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21.5176 Underlying: Common Stock · 1.5436 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:42 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 3,311.68 | $107.68 | $356,585.81 |
DisclosureSEC source: 0001193125-26-106293 · ownership.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,667.32 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $106.52 to $108.65. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 8,464 | $106.80 | $903,957.74 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · nonDerivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,979 F6 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $105.85 to $107.30. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9.38 Underlying: Common Stock · 3 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 13 | $113.69 | $1,477.97 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · nonDerivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,443 F5 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on February 18, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 134 | $113.69 | $15,234.46 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,456 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of PSUs awarded to the reporting person on December 6, 2024. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F3 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 146 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,590 F2 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on February 18, 2025. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on December 6th over the next three years (2026, 2027 and 2028). Read SEC document |
| February 26, 2026 Filed Mar 3, 2026 01:57 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,514 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-086276 · ownership.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,444 F1 · shares: These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001193125-26-041325 · ownership.xml · derivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,054 Underlying: Common Stock · 7 shares Expires 2028-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,672 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001193125-26-041325 · ownership.xml · derivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,672 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7 | $48.60 | $340.20 |
DisclosureSEC source: 0001193125-26-041325 · ownership.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,930 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,672 | $37.29 | $99,638.88 |
DisclosureSEC source: 0001193125-26-041325 · ownership.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · derivative · entry 9 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19.291 Underlying: Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F8 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · derivative · entry 8 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19.974 Underlying: Common Stock · 18 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F7 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/12/2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 302 | $84.00 | $25,368.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · nonDerivative · entry 6 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,251 F4 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · nonDerivative · entry 5 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 302 | $84.00 | $25,368.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · nonDerivative · entry 4 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,535 F3 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/12/2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 18 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · nonDerivative · entry 3 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · derivative · entry 7 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 12/11/2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · balance_after: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 297 | $83.36 | $24,757.92 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · nonDerivative · entry 2 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,819 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on 12/11/2021. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 23:13 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-319552 · ownership.xml · nonDerivative · entry 1 Roberts David B · CIK 0001365731 · Director · President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.